Open Access

ARTICLE

Knockdown of PFTK1 Expression by RNAi Inhibits the Proliferation and Invasion of Human Non-Small Lung Adenocarcinoma Cells

Mei-han Liu^*, Shao-min Shi^†, Kai Li^‡, En-qi Chen^*

* Department of Ultrasonography, China–Japan Union Hospital of Jilin University, Changchun, Jilin Province, China
† Department of Respiratory Medicine, China–Japan Union Hospital of Jilin University, Changchun, Jilin Province, China
‡ Department of Anesthesia, China–Japan Union Hospital of Jilin University, Changchun, Jilin Province, China

Oncology Research 2016, 24(3), 181-187. https://doi.org/10.3727/096504016X14635761799038

Abstract

PFTK1 (PFTAIRE protein kinase 1), also named CDK14 (cyclin-dependent kinase 14), is a member of the cell division cycle 2 (CDC2)-related protein kinase family. It is highly expressed in several malignant tumors. However, the role of PFTK1 in the progression of non-small cell lung cancer (NSCLC) is still elusive. In this study, we aimed to explore the expression and function of PFTK1 in NSCLC cells. Our results showed that PFTK1 was significantly upregulated in human NSCLC cell lines. Silencing the expression of PFTK1 inhibited the proliferation of NSCLC cells. In addition, silencing the expression of PFTK1 endowed NSCLC cells with decreased migration and invasion abilities, as well as epithelial–mesenchymal transition (EMT) progress in A549 cells. A mechanistic study showed that knockdown of PFTK1 inhibited the expression of β-catenin, cyclin D1, and c-Myc in A549 cells. In summary, we report that small interfering RNA (siRNA)-PFTK1 might inhibit the proliferation and invasion of NSCLC cells by suppressing the Wnt/β-catenin signaling pathway. Therefore, PFTK1 may represent a novel therapeutic target for the treatment of NSCLC.

---

Keywords

---